Sequana Medical 2022 BTIG Virtual Conference Presentation

Sequana Medical presented at the BTIG virtual conference on February 16, 2022, discussing innovations in treating diuretic-resistant fluid overload. The company is developing the alfapump® system, a device under clinical investigation in the US and Canada, and DSR® therapy for treating refractory or recurrent ascites due to cirrhosis.